readthroughSign in
CompanyQNCXNasdaqSouth San Francisco, CA

Quince Therapeutics, Inc.

Quince Therapeutics develops eDSP, which encapsulates desipramine into patient red blood cells using its AIDE drug/device platform for ataxia-telangiectasia.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story